HIGHLIGHTS
- who: Yi Zhang from the Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute Tianjin, Huanhu West Road, Hexi District, Tianjin, China have published the Article: The m, in the Journal: (JOURNAL)
- what: The authors confirmed that SMG5 and PP2A coimmunoprecipitated with UPF1, and treating PDAC cells with a potent inhibitor or activator of PP2A results in an increase or decrease in p-UPF1 levels, respectively, consistent with previous reports.
- how: The GSEA results showed that the differentially expressed gene sets were significantly related to the mTOR pathway (Fig 5c). The levels of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.